NCT06733155

Brief Summary

Breast cancer is the most common cancer among women in Singapore, with more than 70 women out of every 100,000 being diagnosed each year. Early detection through regular mammograms can significantly reduce deaths from breast cancer. Although Singapore has had a national breast cancer screening program (now part of the Screen for Life initiative) for over 20 years, and the government offers substantial subsidies to make screening more affordable, participation remains low at only 30-40%. This low uptake is due to factors like fear, lack of awareness, cultural beliefs, and a perceived low risk of breast cancer. To be effective on a large scale, at least 70% of women need to participate in regular mammography screenings. While researchers in Singapore and Asia have studied the reasons behind low screening rates, there is still a lack of large-scale studies that test different strategies to increase mammography participation in these regions. This trial will recruit 12,000 women aged 50-69 who have not undergone a mammogram in the past two years. 9000 women will be randomized into five intervention arms. The interventions include: direct mail reminder (Arm 1, control, n=3000), financial incentive (Arm 2, n=1500), lottery incentive (Arm 3, n=1500), health messaging from an influential figure (Arm 4, n=1500), and personal health concierge for appointment scheduling (Arm 5, n=1500). Another 3000 women will be placed in a non-interventional arm (NI arm) for observational analysis, that receives no reminders at all. A post-intervention telephone survey will assess intervention effectiveness. The primary outcome is mammogram uptake across intervention arms with Arm 1 as a reference. Secondary outcome will be to compare Arm 1 with NI arm. Subgroup analyses will evaluate differences in uptake by sociodemographic factors, such as ethnicity and socioeconomic status. A cost-effectiveness analysis will assess the financial viability of each intervention. This is the first large-scale study in Singapore and Asia to compare multiple interventions to boost mammography uptake. Findings will provide evidence-based strategies to improve breast cancer screening participation, potentially reducing breast cancer mortality and informing future public health policy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 16, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 22, 2025

Status Verified

October 1, 2024

Enrollment Period

4 months

First QC Date

December 10, 2024

Last Update Submit

May 19, 2025

Conditions

Keywords

Breast NeoplasmsMammography

Outcome Measures

Primary Outcomes (1)

  • Comparison of Mammogram Uptake Between Intervention Arms (2-5) and Control Arm

    Primary endpoint: Comparison of the proportion of women who undergo surveillance mammography among participants in Arms 2-5 versus Arm 1 (control arm).

    3 month from study start or 4 months from randomization

Study Arms (6)

Observational Arm

NO INTERVENTION

Does not receive any mailer reminder to go for mammogram.

Arm 1 (control)

EXPERIMENTAL

Receives a mail reminder with basic information about breast cancer and instructions on scheduling a mammogram

Other: Only reminder mailer

Arm 2: Financial incentive

EXPERIMENTAL

Receives mail reminder + a $10 voucher for completing a mammogram within three months.

Other: Financial intervention

Arm 3: Lottery incentive

EXPERIMENTAL

Receives mail reminder + chance to win a $5000 lottery for completing the screening within three months.

Other: Lottery intervention

Arm 4: Health messaging

EXPERIMENTAL

Receives mail reminder + QR code to a 60-second video from an influential person, available in four languages (English, Chinese, Malay, Tamil).

Other: Health Messages

Arm 5: Personal Health Concierge

EXPERIMENTAL

Receives mail reminder + a dedicated hotline for scheduling mammograms with the help of a health concierge over eight weeks.

Other: Personal Health Concierge

Interventions

Participants completing the mammogram within the study end date will receive a $10 voucher.

Arm 2: Financial incentive

Participants completing the mammogram within the study end date will receive achance to win a $5000 lottery.

Arm 3: Lottery incentive

Participants will receive a less than 5 minute long video from an influential person. The video will be available in four languages (English, Chinese, Malay, Tamil).

Arm 4: Health messaging

Participants will be able to call a dedicated hotline for scheduling mammograms with the help of a health concierge over eight weeks of receive the the mailer.

Arm 5: Personal Health Concierge

Receives a mail reminder with basic information about breast cancer and instructions on scheduling a mammogram.

Arm 1 (control)

Eligibility Criteria

Age50 Years - 69 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Singaporean citizen
  • Age 50-69
  • Registered as a patient at the National University Hospital
  • Registered and active user of OneNUHS App
  • Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network

You may not qualify if:

  • Diagnosis of breast cancer in EPIC
  • Mammogram done in the past 24 months in EPIC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, Singapore

Location

Related Publications (1)

  • Lee SC, Lucky SS, Zhu J, Ow S, Loh L, Tan JH, Lim SE, Hairom Z, Mehta S, Tai BC, Goh BC. Pragmatic Interventions to Boost Surveillance Mammogram Uptake Among an Overdue Population: A Randomized Clinical Trial. JAMA Intern Med. 2026 Jan 1;186(1):27-35. doi: 10.1001/jamainternmed.2025.5873.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This study follows a parallel assignment model where participants are randomly assigned to one of five distinct arms: a control arm or one of four intervention arms. Each arm receives a different intervention, and the effects are compared to assess the impact on the uptake of surveillance mammography.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2024

First Posted

December 13, 2024

Study Start

September 16, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

May 22, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations